2-48 hours) inhibits cell cycle progression in 2F7 and BCBL-1 cells
BR102375 (Compound 18) (10 μM) increases gene expression levels relevant to PPARγ activation and enhances glucose uptake under insulin stimulation
1-3H2/t14-
also alters microtubule organization
(±)trans-2, 5-bis-(3, 4, 5-Trimethoxyphenyl)-1, 3-dioxolane Catalog No.:M22691-C 2-48 hours) inhibits cell cycle()trans 2,5 bis (3,4,5 Trimethoxyphenyl) 1,3 dioxolane, also known as trans BTP Dioxolane, is a PAF receptor antagonist . Platelet activating factor (PAF), a phospholipid mediator of inflammation, is secreted by several cell types including arterial endothelial cells, and can activate polymorphonuclear leucocytes and monocytes via specific cell surface receptors. PAF also stimulates the production of active oxygen species by human monocyte derived